New York Life Investment Management’s Verona Pharma VRNA Stock Holding History

New York Life Investment Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-72,467	Closed	-$7.73M	–	857
2025 Q3	$7.73M	Buy	+72,467	New	+$7.57M	0.07%	249

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

New York Life Investment Management's VRNA Position: Q4 2025 in Review

New York Life Investment Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 72,467 shares — an estimated $7.73M sold.

New York Life Investment Management first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $7.73M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

New York Life Investment Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
New York Life Investment Management sold 72,467 Verona Pharma shares in Q4 2025, an estimated $7.73M.
New York Life Investment Management first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
New York Life Investment Management's Verona Pharma position peaked at $7.73M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on New York Life Investment Management's 13F filing for Q4 2025, filed 5 Feb 2026.